1. null
    Eva Lobbens et al, 2017 CrossRef
  2. Botanicals as Modulators of Neuroplasticity: Focus on BDNF
    Enrico Sangiovanni et al, 2017, Neural Plasticity CrossRef
  3. Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
    Rosaliana Libro et al, 2016, Molecules CrossRef
  4. Long-term Treatment with Low-Dose Caffeine Worsens BPSD-Like Profile in 3xTg-AD Mice Model of Alzheimer’s Disease and Affects Mice with Normal Aging
    Raquel Baeta-Corral et al, 2018, Front. Pharmacol. CrossRef
  5. Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates
    Qing-Shan Liu et al, 2017, Mol. Nutr. Food Res. CrossRef
  6. Blockade of adenosine A 2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease
    António C. Silva et al, 2018, Neurobiology of Disease CrossRef
  7. Selected Literature Watch
    , 2013, Journal of Caffeine Research CrossRef
  8. Selected Literature Watch
    , 2013, Journal of Caffeine Research CrossRef
  9. Age Modulates the Association of Caffeine Intake With Cognition and With Gray Matter in Elderly Diabetics
    Rebecca K West et al, 2018 CrossRef
  10. Ameliorative effect of Xiaoyao-jieyu-san on post-stroke depression and its potential mechanisms
    Changde Wang et al, 2018, J Nat Med CrossRef
  11. Impact of Coffee, Wine, and Chocolate Consumption on Cognitive Outcome and MRI Parameters in Old Age
    Sven Haller et al, 2018, Nutrients CrossRef
  12. Extracellular Cardiolipin Regulates Select Immune Functions of Microglia and Microglia-Like Cells
    Caitlin B. Pointer et al, 2019, Brain Research Bulletin CrossRef
  13. null
    Ramón Cacabelos et al, 2014 CrossRef
  14. Caffeine and diphenyl diselenide improve long-term memory impaired in middle-aged rats
    Marlon R. Leite et al, 2014, Experimental Gerontology CrossRef
  15. Caffeine triggers behavioral and neurochemical alterations in adolescent rats
    A.P. Ardais et al, 2014, Neuroscience CrossRef
  16. null
    Khanh vinh quốc Lương et al, 2015 CrossRef
  17. Antidepressant-like effect of essential oil isolated from Toona ciliata Roem. var. yunnanensis
    Dongmei Duan et al, 2015, J Nat Med CrossRef
  18. Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation
    Shanshan Li et al, 2015, JAD CrossRef
  19. Caffeine exposure during rat brain development causes memory impairment in a sex selective manner that is offset by caffeine consumption throughout life
    Ana Paula Ardais et al, 2016, Behavioural Brain Research CrossRef
  20. null
    Nancy Bartolotti et al, 2016 CrossRef
  21. Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation
    Mahmoud L. Soliman et al, 2017, J Neuroimmune Pharmacol CrossRef
  22. Health benefits of methylxanthines in neurodegenerative diseases
    Ainhoa Oñatibia-Astibia et al, 2017, Mol. Nutr. Food Res. CrossRef
  23. The neuroprotective effects of caffeine in neurodegenerative diseases
    Mahshad Kolahdouzan et al, 2017, CNS Neurosci Ther CrossRef
  24. Caffeine impact on working memory-related network activation patterns in early stages of cognitive decline
    Sven Haller et al, 2017, Neuroradiology CrossRef
  25. Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments
    Hailin Zhao et al, 2017, Brain Research CrossRef
  26. Antioxidant and Neuroprotective Effects of Caffeine against Alzheimer’s and Parkinson’s Disease: Insight into the Role of Nrf-2 and A2AR Signaling
    Muhammad Ikram et al, 2020, Antioxidants CrossRef
  27. Exploring new avenues for treating Alzheimer's disease: The rise of natural medicine
    Sarah Lye et al, 2021, Journal of the Neurological Sciences CrossRef
  28. Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
    Piotr Londzin et al, 2021, Nutrients CrossRef
  29. Astrocytes and Adenosine A2A Receptors: Active Players in Alzheimer’s Disease
    Cátia R. Lopes et al, 2021, Front. Neurosci. CrossRef
  30. The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
    null Josiane et al, 2015, Aging and disease CrossRef
  31. Investigation of the Molecular Role of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease
    Pragya Girotra et al, 2021, J Mol Neurosci CrossRef
  32. Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis
    Martina Stazi et al, 2021, Cell. Mol. Life Sci. CrossRef
  33. Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
    Thomas Gabriel Schreiner et al, 2022, Life CrossRef
  34. Tocotrienols Attenuate White Adipose Tissue Accumulation and Improve Serum Cholesterol Concentration in High-Fat Diet-Treated Mice
    Yugo Kato et al, 2022, Molecules CrossRef
  35. Celastrol and thymoquinone alleviate aluminum chloride-induced neurotoxicity: Behavioral psychomotor performance, neurotransmitter level, oxidative-inflammatory markers, and BDNF expression in rat brain
    Faten Abbas et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  36. A comprehensive review on the prevention and regulation of Alzheimer’s disease by tea and its active ingredients
    Yi Huang et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
  37. Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 mice
    Martina Stazi et al, 2022, Eur Arch Psychiatry Clin Neurosci CrossRef
  38. Neuroprotective Effect of Caffeine in Alzheimer’s Disease
    Y Mukish M Yelanchezian et al, 2022, Molecules CrossRef
  39. Associations between urinary caffeine and caffeine metabolites and cognitive function in older adults
    Xihang Fu et al, 2022, Nutritional Neuroscience CrossRef
  40. Post-learning caffeine administration improves ‘what-when’ and ‘what-where’ components of episodic-like memory in rats
    Ana Luiza Alves Dias et al, 2022, Behavioural Brain Research CrossRef
  41. Upregulation of miR-151-5p promotes the apoptosis of intestinal epithelial cells by targeting brain-derived neurotrophic factor in ulcerative colitis mice
    Feng Zhou et al, 2022, Cell Cycle CrossRef
  42. Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect Aβ-GFP SH-SY5Y cells against Aβ toxicity
    Ya-Jen Chiu et al, 2022, Aging CrossRef
  43. Neuroprotective Action of Coumarin Derivatives through Activation of TRKB-CREB-BDNF Pathway and Reduction of Caspase Activity in Neuronal Cells Expressing Pro-Aggregated Tau Protein
    Te-Hsien Lin et al, 2022, IJMS CrossRef
  44. Naringin enhances long-term potentiation and recovers learning and memory deficits of amyloid-beta induced Alzheimer’s disease-like behavioral rat model
    Ga-Young Choi et al, 2022, NeuroToxicology CrossRef
  45. Caffeine protects against hippocampal alterations in type 2 diabetic rats via modulation of gliosis, inflammation and apoptosis
    Manal A. Othman et al, 2022, Cell Tissue Res CrossRef
  46. A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer’s Disease Mouse Model
    Martina Stazi et al, 2023, IJMS CrossRef
  47. Caffeine for Prevention of Alzheimer’s Disease: Is the A2A Adenosine Receptor Its Target?
    Stefania Merighi et al, 2023, Biomolecules CrossRef
  48. null
    Leticia Priscilla Arantes et al, 2023 CrossRef
  49. Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer’s Disease and Parkinson’s Disease
    Victor Tapias et al, 2023, Antioxidants CrossRef
  50. null
    Yan Zhao et al, 2023 CrossRef
  51. Blockade of adenosine A2A receptors reverses early spatial memory defects in the APP/PS1 mouse model of Alzheimer’s disease by promoting synaptic plasticity of adult-born granule cells
    Qi Ji et al, 2023, Alz Res Therapy CrossRef
  52. Mixing energy drinks and alcohol during adolescence impairs brain function: a study of rat hippocampal plasticity
    Francesca Biggio et al, 2024, Neuropharmacology CrossRef
  53. null
    Parvathy G. Nair et al, 2024 CrossRef
  54. null
    Foad Mirzaei et al, 2024 CrossRef